When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Newron today announces its financial and operational results for the half year ended June 30, 2024, and provides an update on ...

ALG-055009 dose groups met the primary endpoint with statistically significant reductions in liver fat at Week 12 as measured ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved ...

GILD Stock Soars on HIV Drug Data: Gilead’s shares gained after the company announced upbeat results from an interim analysis of a second late-stage study evaluating the use of the company’s ...

The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

The FDA has cleared the Epitomee capsule to support weight management in adults with a body mass index of 25 to 40kg/m2.

Gefapixant decreased cough-induced stress urinary incontinence (CSUI) episodes in women with refractory/unexplained chronic cough and CSUI.

today announced it has submitted to the FDA its PF614-301 protocol of the study, "A Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled Study to Evaluate the Efficacy and Safety of ...

Aligos Therapeutics, Inc. (ALGS), a clinical stage biopharmaceutical company focused on liver and viral diseases, announced Thursday ...